126 related articles for article (PubMed ID: 37330155)
1. Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma.
Hariharan K; Mehta T; Shah J; Dave H; Sami A; Omri A
Int J Pharm; 2023 Jul; 642():123144. PubMed ID: 37330155
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas.
Wang X; Li S; Liu H
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102218. PubMed ID: 33592329
[TBL] [Abstract][Full Text] [Related]
3. Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma.
Mohan A; Narayanan S; Balasubramanian G; Sethuraman S; Krishnan UM
Eur J Pharm Biopharm; 2016 Feb; 99():73-83. PubMed ID: 26690333
[TBL] [Abstract][Full Text] [Related]
4. Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma.
Chen X; Chen DR; Liu H; Yang L; Zhang Y; Bu LL; Sun ZJ; Cai L
J Control Release; 2022 Nov; 351():381-393. PubMed ID: 36096364
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of TPGS-based stealth liposome of doxorubicin using Box-Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells.
Kurmi BD; Paliwal SR
J Liposome Res; 2022 Jun; 32(2):129-145. PubMed ID: 33724151
[TBL] [Abstract][Full Text] [Related]
6. Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2).
Chan CY; Hong SC; Chang CM; Chen YH; Liao PC; Huang CY
Cells; 2023 Jan; 12(1):. PubMed ID: 36611972
[TBL] [Abstract][Full Text] [Related]
7. Photocytotoxicity of liposomal zinc phthalocyanine in oral squamous cell carcinoma and pharyngeal carcinoma cells.
Cheung J; Furukawa D; Pandez R; Yıldırım M; Frazier A; Piskorz J; Düzgüneş N; Konopka K
Ther Deliv; 2020 Sep; 11(9):547-556. PubMed ID: 32933409
[No Abstract] [Full Text] [Related]
8. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
9. Thermosensitive and mucoadhesive hydrogel containing curcumin-loaded lipid-core nanocapsules coated with chitosan for the treatment of oral squamous cell carcinoma.
Ortega A; da Silva AB; da Costa LM; Zatta KC; Onzi GR; da Fonseca FN; Guterres SS; Paese K
Drug Deliv Transl Res; 2023 Feb; 13(2):642-657. PubMed ID: 36008703
[TBL] [Abstract][Full Text] [Related]
10. Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma
Mangla B; Mittal P; Kumar P; Javed S; Ahsan W; Aggarwal G
Nanomedicine (Lond); 2024 Apr; 19(10):855-874. PubMed ID: 38440976
[TBL] [Abstract][Full Text] [Related]
11. Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy.
Pardeshi S; Tiwari A; Titame U; Singh PK; Yadav PK; Chourasia MK
J Liposome Res; 2022 Dec; 32(4):386-395. PubMed ID: 35225132
[TBL] [Abstract][Full Text] [Related]
12. Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.
Benhamou Y; Picco V; Raybaud H; Sudaka A; Chamorey E; Brolih S; Monteverde M; Merlano M; Lo Nigro C; Ambrosetti D; Pagès G
Oncotarget; 2016 Jul; 7(28):44236-44251. PubMed ID: 27329590
[TBL] [Abstract][Full Text] [Related]
13. Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes.
Tang WL; Tang WH; Chen WC; Diako C; Ross CF; Li SD
Mol Pharm; 2017 Jun; 14(6):1969-1979. PubMed ID: 28460165
[TBL] [Abstract][Full Text] [Related]
14. Phototoxicity of Liposomal Zn- and Al-phthalocyanine Against Cervical and Oral Squamous Cell Carcinoma Cells In Vitro.
Young J; Yee M; Kim H; Cheung J; Chino T; Düzgüneş N; Konopka K
Med Sci Monit Basic Res; 2016 Dec; 22():156-164. PubMed ID: 27932777
[TBL] [Abstract][Full Text] [Related]
15. Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.
Tsien CI; Nyati MK; Ahsan A; Ramanand SG; Chepeha DB; Worden FP; Helman JI; D'Silva N; Bradford CR; Wolf GT; Lawrence TS; Eisbruch A
Head Neck; 2013 Sep; 35(9):1323-30. PubMed ID: 22907806
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone.
Wang M; Liu M; Xie T; Zhang BF; Gao XL
Colloids Surf B Biointerfaces; 2017 Nov; 159():580-585. PubMed ID: 28854414
[TBL] [Abstract][Full Text] [Related]
17. GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect.
Priya V; Singh SK; Revand R; Kumar S; Mehata AK; Sushmitha P; Mahto SK; Muthu MS
Mol Pharm; 2023 Jan; 20(1):663-679. PubMed ID: 36413707
[TBL] [Abstract][Full Text] [Related]
18. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications.
Hua S; Vaughan B
Int J Nanomedicine; 2019; 14():2191-2206. PubMed ID: 30988616
[TBL] [Abstract][Full Text] [Related]
19. QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation.
Kesharwani P; Md S; Alhakamy NA; Hosny KM; Haque A
Polymers (Basel); 2021 Jan; 13(2):. PubMed ID: 33451016
[TBL] [Abstract][Full Text] [Related]
20. CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice.
Soleimani A; Mirzavi F; Nikoofal-Sahlabadi S; Nikpoor AR; Taghizadeh B; Barati M; Soukhtanloo M; Jaafari MR
Sci Rep; 2022 Jun; 12(1):10423. PubMed ID: 35729230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
